HHS Seeks to Spur Breakthroughs in Treating Kidney Disease

zlikovec/Shutterstock

The KidneyX Innovation Accelerator incentivizes entrepreneurs and innovators to revolutionize the way kidney disease is treated.

A nascent project launched by the Health and Human Services Department aims to spur innovation and help solve an expensive health crisis plaguing millions of Americans: kidney disease.

Developers hope it will one day be used as a model not only for introducing innovators to government, but for addressing other high-cost diseases.

HHS Open Innovation Manager Dr. Sandeep Patel discussed the project—dubbed the KidneyX Innovation Accelerator—at ACT-IAC’s Health Innovation Day in Washington April 10, encouraging innovators to get involved.

“For a long time, there’s been a sense of hopelessness [in the field of kidney research] and we are trying to turn that around by making it an area of opportunity and a place where innovators should think about spending their time and their money,” Patel said.

KidneyX is a public-private partnership between HHS and the American Society of Nephrology, and seeks to accelerate innovation in the prevention, diagnosis and treatment of frequently fatal kidney disease. The project is product-driven, with a goal of targeting entrepreneurs and innovators who don’t automatically think about applying to grant solicitations or working with the federal government to address health emergencies. It seeks to eventually ensure that kidney patients have access to ground-breaking therapies and technologies for treatment.

Presently, there is no deadline for the project to wrap up.

“KidneyX is designed to be catalytic, so we only want to last as long as we think there needs to be some catalytic effect here,” Patel told Nextgov in an interview following his April 10 remarks. “We are not necessarily planning for it to exist until all products developed are in the market, which could take a long time. It’s just until we get to a phase where we think there’s a healthy amount of activity, investment and people working on the problem.”

The accelerator is initially operating through a series of monetary prizes. Its inaugural endeavor, KidneyX: Redesign Dialysis, launched last year and will run in two (and potentially more) phases, with a total prize purse of more than $2.6 million.

The first phase, which will award up to 15 prizes of $75,000 each, asks participants to “design solutions that can replicate normal kidney functions and improve patient quality of life.” Patel said HHS received 165 admissions in phase one and winners will be awarded at the end of April.

The second phase will run from April through January 2020 and award up to 3 prizes of $500,000 each to participants who develop testable early-stage pre-human trial prototypes of wearable or implantable devices designed to treat kidney disease and failure.

“The goal is to accelerate the development of devices that go into human trials,” Patel said. He also noted that the KidneyX team is scoping out opportunity areas and prizes around diagnostics and prevention for future phases of the accelerator.

Kidney disease and failure may not receive the same attention as other major health crises, but Patel said it’s an “undeniably and incredibly important and solvable problem.”

Kidney disease affects  30 to 40 million people in the United States, and more than 800 million people battle it worldwide. Patel noted about half of those who have advanced kidney disease don’t even realize it.

“It’s really terrifying. I've spoken to a lot of patients about it and they will tell you that their diagnosis was sort of a fog,” he said. “They went to the doctor for some other health issue and all of a sudden realize they are put on dialysis without even recognizing what happened.”

Patel also explained that every year at least 100,000 people begin dialysis—the primary treatment for kidney failure that filters toxins from the blood—and yet the therapy hasn’t fundamentally changed since it was invented in 1962.

“Just think about this time frame and think about all the things that were invented from 1962 until now,” Patel said. “Entire industries were created and entire industries were destroyed and yet this was the time frame in which dialysis remained fairly constant.”  

Half of those who begin dialysis also die within 5 years, a mortality rate similar to many cancers. The treatment is also invasive and consumes patients’ lives.

“If you are on dialysis it is your life. You are in treatment at least three times a week and four to five hours a day and when you’re not on dialysis, you are tired and thinking about your next session,” Patel said. “You spend your life essentially chained to a machine.”

The therapy automatically qualifies patients for Medicare and is expensive, Patel said, costing taxpayers some $114 billion each.

Due to the disease's’ devastating impact on patients’ lives, the KidneyX team decided to make the accelerator “patient-centric and patient-driven.” People who are on dialysis or suffer from kidney disease are involved in all phases of the project.

“We thought this was very important because patients have a compelling story to tell and really important elements around their experiences can get lost in product development. So we want to make sure all the entrepreneurs, innovators and product developers that we are trying to support and recruit understand patient insights early on,” Patel said.

All of the project’s submissions, no matter how technical, must involve conversations and insights drawn from patients, and patients are also involved in the review and award process.

“We have had nothing but positive feedback on this,” Patel said. “The people I talked to who helped out in the review were really interested in seeing what people were thinking about and enjoyed having their voices heard as a part of the process.”

The culture within the federal government also has a reputation of stifling innovation and Patel said the issue was sometimes challenging for he and his team to navigate.

“It can be very difficult to do anything outside of the norm, for sure,” he said.

But what Patel said he’s found to work best so far is uniting people from a variety of different sectors and building a community between them.

“A lot of it is just about bringing people together and trying to really do something in a manageable way as quickly as possible,” he said.  

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.